News from oncosec medical inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 13, 2014, 06:03 ET

OncoSec Medical To Present At The Third Annual Marcum MicroCap Conference

 OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, announced today that...

Aug 15, 2013, 08:35 ET

Excitement Builds as Electrical Pulses Prove Potent Against Advanced Skin Cancers

 We have come a long way in the use of electricity. In ancient Greece, Thales of Miletus discovered he could produce electrical sparks by...

Mar 25, 2013, 06:07 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients

 OncoSec Medical Inc. (OTCQB: ONCS) – a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy...

Mar 18, 2013, 06:09 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at the HemOnc Today Melanoma and Cutaneous Malignancies Meeting in New York

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Mar 14, 2013, 06:07 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at the 25th Annual Roth Conference

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Feb 26, 2013, 06:14 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Announces Formation of Melanoma Advisory Board

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Feb 19, 2013, 06:07 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Promotes Veronica Vallejo to Chief Financial Officer

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Feb 06, 2013, 06:00 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Jan 17, 2013, 06:08 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at Noble Financial Capital Markets' Ninth Annual Equity Conference on January 22

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Jan 15, 2013, 06:08 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Announces 2013 Milestones and Corporate Strategy

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Jan 03, 2013, 06:08 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at Biotech Showcase(TM) 2013 in San Francisco on January 8

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Dec 13, 2012, 09:30 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Announces $7.2 Million Public Offering

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Dec 04, 2012, 06:08 ET
OncoSec Medical is focused on pursuing new business opportunities in the biomedical field.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present Data at DNA Vaccines 2012 Conference

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Nov 27, 2012, 06:08 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at NYSSA Life Sciences and LD Micro Investor Conferences

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Nov 15, 2012, 06:02 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Nov 14, 2012, 06:06 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat...

Oct 23, 2012, 06:07 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical Incorporated Reports Positive Preliminary Efficacy and Safety Results from Phase II Study of ImmunoPulse in Merkel Cell Carcinoma Patients

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to...

Oct 17, 2012, 06:07 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Receives CE Mark for Its Electroporation Device

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse drug-based...

Oct 09, 2012, 06:08 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present Data at Two Upcoming Conferences

 OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to...

Oct 02, 2012, 06:09 ET
OncoSec Medical Logo.  (PRNewsFoto/OncoSec Medical Incorporated)

OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapies to treat...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge